ArticleJournal of the American Chemical Society2023
Chiral Perovskite Nanocrystals for Asymmetric Reactions: A Highly Enantioselective Strategy for Photocatalytic Synthesis of N-C Axially Chiral Heterocycles.
Article in Journal of the American Chemical Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Primitive Ligands Drive 1D CsPbIAngewandte Chemie (International ed. in English) · 2026Article
- Enantioselective Modulation of Inflammatory Response through MAPK Pathway by Wavelike Chiral Nanoparticles.Environment & health (Washington, D.C.) · 2025Article
- Chiral heterogeneous photocatalysts for enantioselective synthesis: standing on the shoulders of organocatalysis.Chemical science · 2025Review
- Halide Perovskite Photocatalysts for Clean Fuel Production and Organic Synthesis: Opportunities and Challenges.Advanced materials (Deerfield Beach, Fla.) · 2025Review
- Highly enantioselective synthesis controlled by spin-exchange interaction.Science advances · 2025Article
- Emerging Opportunities of Colloidal Quantum Dots for Photocatalytic Organic Transformations.Advanced materials (Deerfield Beach, Fla.) · 2025Review
- Merging of Two Photoredox Cycles with One Perovskite Catalyst Achieving Dual Functionalization: N-Heterocyclization and Site-Selective Bromination of N-Arylamines.The Journal of organic chemistry · 2025Article
- Halide Perovskite Induces Halogen/Hydrogen Atom Transfer (XAT/HAT) for Allylic C-H Amination.Angewandte Chemie (International ed. in English) · 2025Article
- Inducing Efficient and Multiwavelength Circularly Polarized Emission From Perovskite Nanocrystals Using Chiral Metasurfaces.Advanced materials (Deerfield Beach, Fla.) · 2024Article
- Chirality Detection in Scanning Tunneling Microscopy Data Using Artificial Intelligence.Small methods · 2024Article
- Spin-related excited-state phenomena in photochemistry.National science review · 2024Article
- Deciphering charge transfer dynamics of a lead halide perovskite-nickel(ii) complex for visible light photoredox C-N coupling.Chemical science · 2024Article
- General, Modular Access toward Immobilized Chiral Phosphoric Acid Catalysts and Their Application in Flow Chemistry.ACS catalysis · 2024Article
- Photocatalysis Based on Metal Halide Perovskites for Organic Chemical Transformations.Nanomaterials (Basel, Switzerland) · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Catalytic approaches to generate enantiospecific chiral centers are the major premise of modern organic chemistry. Heterogeneous catalysis is responsible for the vast majority of chemical transformations, yet the direct employment of chiral solid catalysts for asymmetric synthesis is mostly overlooked. Here, we demonstrated that a heterogeneous metal-halide perovskite nanocrystal (NC) catalyst is active for asymmetric organic synthesis under visible-light activation. Chiral 1-phenylethylamine (PEA)-hybridized perovskite PEA/CsPbBr
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.